Andrew, B., Iversen, E. S., Lancaster, J. M., Dressman, H. K., West, M., Nevins, J. R., … Miller, B. E. (2004). Prediction of optimal versus suboptimal cytoreduction of advanced-stage serious ovarian cancer with the use of microarrays. Women’s Oncology Review. https://doi.org/10.1080/14733400412331312585

Andrew, B., E. S. Iversen, J. M. Lancaster, H. K. Dressman, M. West, J. R. Nevins, J. R. Marks, and B. E. Miller. “Prediction of optimal versus suboptimal cytoreduction of advanced-stage serious ovarian cancer with the use of microarrays.” Women’s Oncology Review, September 1, 2004. https://doi.org/10.1080/14733400412331312585.

Andrew B, Iversen ES, Lancaster JM, Dressman HK, West M, Nevins JR, et al. Prediction of optimal versus suboptimal cytoreduction of advanced-stage serious ovarian cancer with the use of microarrays. Vol. 4, Women’s Oncology Review. 2004. p. 203–4.

Andrew, B., et al. “Prediction of optimal versus suboptimal cytoreduction of advanced-stage serious ovarian cancer with the use of microarrays.” Women’s Oncology Review, vol. 4, no. 3, 1 Sept. 2004, pp. 203–04. Scopus, doi:10.1080/14733400412331312585.

Andrew B, Iversen ES, Lancaster JM, Dressman HK, West M, Nevins JR, Marks JR, Miller BE. Prediction of optimal versus suboptimal cytoreduction of advanced-stage serious ovarian cancer with the use of microarrays. Women’s Oncology Review. 2004. p. 203–204.